|
|
||||
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
|
|
[ SPOREs: Brain | Breast | GI | GU | GYN | Head and Neck | Leukemia | Lung | Lymphoma | Myeloma | Ovarian | Pancreatic | Prostate | Skin ] Pancreatic SPOREsPancreatic cancer is the 5th leading cause of cancer death in the United States. Over 33,000 newly diagnosed cases, and an estimated 32,300 deaths will be expected in the United States in the year 2006. Presently, surgery, radiation and chemotherapies are treatment options that can extend survival and/or relieve symptoms in these patients, but seldom produce a cure. Patients with cancers of the pancreas have a particularly poor prognosis, as mortality from of this cancer is extremely high (5-year survival rate is about 4%). The pancreatic cancer SPORE program was initiated in the year 2002 and three SPOREs (one P50 and two P20) have been awarded. Currently, the investigators from pancreatic cancer SPOREs are working closely with the researchers in GI Cancer SPOREs.
To view the abstracts for the P50 SPOREs, please click on the name/address below. |
 |
|||
|
|